In brief
Chinese health‑ingredient firms at SupplySide Global 2026 in Las Vegas presented a renewed focus on branded finished goods, with Ganoherb and Changsha Huir announcing plans to establish U.S. manufacturing hubs. In an industry where Chinese suppliers provide about 80% of raw materials, the companies aim to climb the value chain and create integrated supply chains. Experts note that the success of these moves remains untested, and uncertainties about market reception and regulatory hurdles have not yet been resolved.
At the conclusion of SupplySide Global 2026 in Las Vegas, more than 1,600 exhibitors and over 20,000 professionals gathered, including a record‑high nearly 600 Chinese companies, according to Chinese event organizers. The expo, held at Mandalay Bay, highlighted a shift by Chinese producers from supplying raw ingredients to developing high‑value finished dietary supplements and building their own brands.
Among the exhibitors, Ganoherb Group, a major producer of organic lingzhi—also known as reishi mushroom—products, long supplied raw materials and OEM services to overseas clients. Facing intense price competition, the company's president and founder Li Ye told Xinhua that Ganoherb plans to focus more on branded products in the U.S. market. This strategy includes reishi mushroom coffee and tea made with concentrated extracts, showcased at the expo.
Changsha Huir Biological‑tech Co., Ltd., headquartered in Hunan Province, also announced plans to move up the value chain. General manager Yuan Zhi said the company has supplied natural extracts and other health ingredients overseas for over a decade and now intends to build a U.S. processing facility to manufacture finished products for global distribution. He added that China’s diverse raw‑material sources and increasingly automated, energy‑efficient production equipment give Chinese firms a competitive edge. The new facility, once operational, would extend the company’s business beyond ingredient supply and create a more integrated supply chain.
Industry observers noted that Chinese suppliers remain essential to the global dietary supplement industry. Loren Israelsen, president of the United Natural Products Alliance, told Xinhua that China supplies roughly 80 percent of the industry's raw materials. “Having good Chinese suppliers is fundamental to the success of the American marketplace and to serving….” his statement ended abruptly in the article, leaving the precise implications unclear.
The event also hosted a China Innovative Health Ingredients Brand Show, which brought together more than 60 Chinese companies to present products and technological advances. This parallel showcase reinforced the broader trend of Chinese firms seeking greater participation as finished‑product manufacturers in the U.S. and other Western markets.
Experts caution that while the announcements of U.S. processing facilities and increased branding represent clear intent, the practical realization of these plans remains uncertain. Questions linger about regulatory approvals, distribution logistics, and consumer acceptance of Chinese‑branded products in the United States. The long‑term competitive positioning of these firms against established Western brands has not yet been demonstrated.
In summary, Chinese health‑ingredient companies showcased at SupplySide Global 2026 that they are shifting toward high‑value finished goods and building U.S. manufacturing hubs. They count on China’s raw‑material supply strengths and aim for a more integrated supply chain. However, the ultimate success of these strategies, including market adoption, regulatory hurdles, and competitive dynamics, remain the primary uncertainties identified by the sources.”}
